Donald Stanford
Psychiatry · Berkeley, CANPI 1861400657
Payments from drug & device makers
Across 785 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$5K
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$2K
- Bausch Health US, LLC$1K
- Lundbeck LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$976
- plus $5K from 20 others
What the payments were for
- Consulting fees$4,57525%
- Food & beverage$13,45875%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1 | $4,575 |
| AbbVie(2 entities) | 170 | $2,472 |
| Sunovion Pharmaceuticals Inc. | 191 | $2,420 |
| Bausch Health US, LLC | 70 | $1,264 |
| Lundbeck LLC | 59 | $1,207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $976 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $838 |
| Otsuka America Pharmaceutical, Inc. | 36 | $735 |
| Vanda Pharmaceuticals Inc. | 31 | $706 |
| Ironshore Pharmaceuticals Inc. | 25 | $455 |
| Neurocrine Biosciences, Inc. | 8 | $399 |
| Alkermes, Inc. | 13 | $352 |
| Adlon Therapeutics L.p. | 15 | $278 |
| Shire North American Group Inc | 19 | $208 |
| Corium, LLC | 14 | $208 |
| Teva Pharmaceuticals USA, Inc. | 5 | $204 |
| Johnson & Johnson | 6 | $204 |
| Eisai Inc. | 10 | $163 |
| Harmony Biosciences LLC | 6 | $128 |
| Neos Therapeutics, LP | 7 | $116 |
| Vertical Pharmaceuticals, LLC | 1 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,038 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 64 | $2,727 |
| Methylphenidate Hcl | 41 | $1,462 |
| Lamotrigine | 24 | $588 |
| Bupropion XlBupropion Hcl | 15 | $313 |
| Clonazepam | 23 | $285 |
| Alprazolam | 33 | $264 |
| Bupropion Hcl SrBupropion Hcl | 15 | $219 |
| Fluoxetine Hcl | 11 | $203 |
| Quetiapine Fumarate | 13 | $179 |
| Lorazepam | 56 | $170 |
| Olanzapine | 13 | $157 |
| Zolpidem Tartrate | 23 | $149 |
| Diazepam | 25 | $143 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Berkeley
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.